Intellia Therapeutics Inc

NASDAQ: NTLA
Share price (5/14/24): $25.73
Market cap (5/14/24): $2.482 billion

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

4 Intellia Therapeutics Inc Expert Interviews, now on BamSEC.

Powered by Tegus.

Financials Filter

ended 03/31/24 Q1

ended 12/31/23 FY 2023

ended 09/30/23 Q3

ended 06/30/23 Q2

ended 03/31/23 Q1

Prospectuses and Registrations Filter

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Registration of securities for employees

Automatic shelf registration

Registration of securities for employees

Ownership Filter

Sepp-Lorenzino Laura

News Filter

Announces First Quarter 2024 Financial Results and Highlights Recent Company Progress

Announces Publication of Positive Interim Phase 1 Data for NTLA-2002 in Patients With Hereditary Angioedema in the New England Journal of Medicine

Termination of Material Definitive Agreement

Amendment No. 1 to the Open Market Sale Agreementsm

Announces Fourth Quarter and Full-Year 2023 Financial Results and Highlights Recent Company Progress

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Preliminary proxy

Additional info about upcoming vote

Additional info about upcoming vote

Other Filter

Scanned paper annual report submission

Scanned paper annual report submission

Confidential treatment order

Notice of effectiveness

Correspondence with the SEC